Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia
The IL-3 alpha chain receptor (CD123) is a cell surface protein that is widely expressed by various subtypes of acute leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia and blastic plasmacytoid dendritic cell neoplasm. Notably, CD123 is preferentially overexpressed in leu...
Main Authors: | Ibrahim Aldoss, Mary Clark, Joo Y Song, Vinod Pullarkat |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Taylor & Francis Group
2020-10-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Acceso en liña: | http://dx.doi.org/10.1080/21645515.2020.1788299 |
Títulos similares
-
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients
por: Naveen Pemmaraju, et al.
Publicado: (2024-02-01) -
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies
por: Shefali Mehra, et al.
Publicado: (2024-01-01) -
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
por: Haotian Ma, et al.
Publicado: (2024-11-01) -
Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports
por: Philipp Faustmann, et al.
Publicado: (2024-04-01) -
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
por: Justin C. Boucher, et al.
Publicado: (2023-12-01)